110 related articles for article (PubMed ID: 7966234)
1. Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
Warren JT; Dolatshahi M
J Med Primatol; 1994; 23(2-3):184-225. PubMed ID: 7966234
[No Abstract] [Full Text] [Related]
2. Fourth annual survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
Warren JT; Levinson MA
J Med Primatol; 1995 May; 24(3):150-68. PubMed ID: 8751055
[No Abstract] [Full Text] [Related]
3. Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates.
Warren J
J Med Primatol; 2002 Aug; 31(4-5):237-56. PubMed ID: 12390546
[TBL] [Abstract][Full Text] [Related]
4. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
[TBL] [Abstract][Full Text] [Related]
5. AIDS vaccines show promise in primates.
Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
[No Abstract] [Full Text] [Related]
6. Vaccines. Monkey puzzles.
Cohen J
Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
[No Abstract] [Full Text] [Related]
7. AIDS vaccines. Long-lasting immunity conferred in monkeys.
Cohen J
Science; 2001 Mar; 291(5510):1879-81. PubMed ID: 11245180
[No Abstract] [Full Text] [Related]
8. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
9. Alternative HIV vaccine strategies.
Lehner T; Shearer GM
Science; 2002 Aug; 297(5585):1276-7. PubMed ID: 12194176
[No Abstract] [Full Text] [Related]
10. Determining the immune mechanisms of protection from AIDS: correlates of immunity and the development of syngeneic macaques.
Kent SJ; Ada GL; Hayes E; Lewis IM
Immunol Rev; 2001 Oct; 183():94-108. PubMed ID: 11782250
[TBL] [Abstract][Full Text] [Related]
11. AIDS preclinical vaccine development: biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
Warren JT; Levinson MA
J Med Primatol; 1999; 28(4-5):249-73. PubMed ID: 10593492
[No Abstract] [Full Text] [Related]
12. Preclinical AIDS vaccine development: formal survey of global HIV, SIV, and SHIV in vivo challenge studies in vaccinated nonhuman primates.
Warren JT; Levinson MA
J Med Primatol; 1997; 26(1-2):63-81. PubMed ID: 9271191
[No Abstract] [Full Text] [Related]
13. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
14. Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.
Lifson JD; Haigwood NL
Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007310. PubMed ID: 22675663
[TBL] [Abstract][Full Text] [Related]
15. An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS.
Wang SW; Bertley FM; Kozlowski PA; Herrmann L; Manson K; Mazzara G; Piatak M; Johnson RP; Carville A; Mansfield K; Aldovini A
AIDS Res Hum Retroviruses; 2004 Aug; 20(8):846-59. PubMed ID: 15320989
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccination for HIV-1 and SIV.
Barouch DH; Letvin NL
Intervirology; 2000; 43(4-6):282-7. PubMed ID: 11251383
[TBL] [Abstract][Full Text] [Related]
17. Nonhuman primate models for HIV vaccine development.
Letvin NL
Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
[TBL] [Abstract][Full Text] [Related]
18. Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol.
Ramsburg E; Rose NF; Marx PA; Mefford M; Nixon DF; Moretto WJ; Montefiori D; Earl P; Moss B; Rose JK
J Virol; 2004 Apr; 78(8):3930-40. PubMed ID: 15047809
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic dendritic-cell vaccine for simian AIDS.
Lu W; Wu X; Lu Y; Guo W; Andrieu JM
Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
